Baris Erdogan (featured image), currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021. After a three-year tenure, Clinerion’s current CEO, Ian Rentsch, has decided to step down for personal reasons and to return to his family in Berlin by the end of January, 2021.
Pierre Jaccoud, Chairman of Clinerion’s Board of Directors, noted that the company is grateful for Rentsch’s achievements in developing Clinerion as a leader in the fast-developing world of real-world data solutions. “We regret losing Ian, but sympathize with his personal reasons for returning to Berlin to focus on his personal health and family. We wish Ian every success and are thankful that we can continue our relationship beyond his formal exit date,” Jaccound said.
He said that Rentsch will support the transition to Baris Erdogan until the end of January, 2021. Furthermore, he said that for the Board of Directors, Baris is the ideal successor as CEO.
“He knows Clinerion, our excellent employees and outstanding technology, and has in-depth understanding of clinical research. He will continue to drive Clinerion on the path set by Ian. We are happy that we can fill the CEO position through internal promotion, which demonstrates the quality of “the Bench” at Clinerion. He has the full support of the Board.”